Book provides up-to-date knowledge about mild cognitive impairment

At least one in ten adults over the age of 65 suffers from Mild Cognitive Impairment, or MCI. This condition, a state between the normal decline in cognition associated with aging and the more precipitous drop caused by a deadly dementia like Alzheimer's disease, has only recently begun to be studied; first identified by the Mayo Clinic in 1999, it was only given an official diagnostic code in late 2006. As a result, despite its prevalence - and its seriousness: it's often a precursor to Alzheimer's disease, one of the top ten causes of death in the United States - MCI remains almost entirely unknown to the public.

Three noted psychologists are now taking one of the first steps toward filling in this gap. LIVING WITH MILD COGNITIVE IMPAIRMENT: A Guide to Maximizing Brain Health and Reducing Risk of Dementia is the first book to be published on MCI for the general reader. Specifically written for individuals with mild cognitive impairment (MCI), for their family members, and for the health care professionals with whom they navigate their journey with MCI, the book provides up-to-date, scientifically substantiated knowledge about what MCI is, how it affects people, and how to take a proactive approach to health and wellbeing for living with the condition; the renowned British clinical psychologist Linda Clare describes it as "An invaluable resource for anyone living with MCI or wanting to understand more about this little-known and poorly-understood, but widespread, condition."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common cardiovascular drugs linked to lower risk of dementia